Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lexicon Pharmaceutcl
(NQ:
LXRX
)
1.690
+0.020 (+1.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Lexicon Pharmaceutcl
< Previous
1
2
3
4
5
Next >
Should You Buy This Growth Stock Right Now Before It Potentially Doubles?
April 22, 2023
It could skyrocket or it could tank, but it probably won't be sitting still soon.
Via
The Motley Fool
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 17, 2023
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.
Via
Benzinga
Lexicon Pharmaceuticals's Return On Capital Employed Insights
March 08, 2023
Via
Benzinga
Earnings Preview For Lexicon Pharmaceuticals
March 01, 2023
Via
Benzinga
Lexicon Pharmaceuticals's Return On Capital Employed Overview
December 14, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
March 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 03, 2023
Via
Benzinga
Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday
March 03, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 03, 2023
Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.
Via
Benzinga
Lexicon Pharma's Pain Candidate Fails In Postherpetic Neuralgia Study
December 22, 2022
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) announced the topline results of RELIEF-PHN-1 Phase 2 proof-of-concept study of LX9211 in postherpetic neuralgia, a lasting pain in the areas of the skin that...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 22, 2022
Via
Benzinga
Micron, Lexicon Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
December 22, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. Westrock Coffee Company, LLC (NASDAQ: WEST) shares tumbled 10.9% to $11.90...
Via
Benzinga
Why ORIC Pharmaceuticals Shares Are Trading Higher By Around 46%; Here Are 27 Stocks Moving Premarket
December 22, 2022
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares rose 77.7% to $0.0906 in pre-market trading. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
Lexicon's Experimental Drug Shows Significant, Consistent Benefits In Diabetic Neuropathy Study
November 15, 2022
Via
Benzinga
Earnings Outlook For Lexicon Pharmaceuticals
November 08, 2022
Lexicon Pharmaceuticals (NASDAQ:LXRX) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
August 12, 2022
Via
Benzinga
Recap: Lexicon Pharmaceuticals Q2 Earnings
August 02, 2022
Lexicon Pharmaceuticals (NASDAQ:LXRX) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Lexicon...
Via
Benzinga
More Than $40 Million Bet On This Penny Stock? Check Out These 3 Penny Stocks Insiders Are Buying
August 02, 2022
U.S. gold futures traded higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
This Financial Services Is Trading Higher By Over 217%; Here Are 38 Stocks Moving Premarket
August 02, 2022
Gainers AMTD IDEA Group (NYSE: AMTD) rose 217.3% to $6.60 in pre-market trading after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Via
Benzinga
Lexicon Pharmaceuticals Earnings Preview
August 01, 2022
Lexicon Pharmaceuticals (NASDAQ:LXRX) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Earnings Scheduled For August 2, 2022
August 02, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
Via
Benzinga
Why Amazon Is Trading Higher By 12%: Here Are 23 Stocks Moving Premarket
July 29, 2022
Gainers Getty Images Holdings, Inc. (NYSE: GETY) rose 104.5% to $21.47 in pre-market trading.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 28, 2022
Via
Benzinga
Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate
July 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
July 29, 2022
Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,...
Via
Benzinga
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
July 28, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 28, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
July 28, 2022
Good morning! It's time for another dive into the biggest pre-market stock movers as we check out what's happening Thursday morning!
Via
InvestorPlace
Why Meta Platforms Is Trading Lower By More Than 6%: Here Are 34 Stocks Moving Premarket
July 28, 2022
Gainers JAKKS Pacific, Inc. (NASDAQ: JAKK) rose 34.7% to $23.01 in pre-market trading after the company reported better-than-expected Q2 results.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.